Cargando…
The emerging role of cell-free DNA as a molecular marker for cancer management
An increasing number of studies demonstrate the potential use of cell-free DNA (cfDNA) as a surrogate marker for multiple indications in cancer, including diagnosis, prognosis, and monitoring. However, harnessing the full potential of cfDNA requires (i) the optimization and standardization of preana...
Autores principales: | Bronkhorst, Abel Jacobus, Ungerer, Vida, Holdenrieder, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425120/ https://www.ncbi.nlm.nih.gov/pubmed/30923679 http://dx.doi.org/10.1016/j.bdq.2019.100087 |
Ejemplares similares
-
Considerations and quality controls when analyzing cell-free tumor DNA
por: Johansson, Gustav, et al.
Publicado: (2019) -
Guest editor’s editorial: BDQ Special Issue — “Liquid Biopsy & Next Generation Biomarkers”: Published in conjunction with the 9th Gene Quantification Event in Freising Weihenstephan, Germany www.qPCR-dPCR-NGS-2019.net
por: Pfaffl, Michael W.
Publicado: (2019) -
For what factors should we normalize urinary extracellular mRNA biomarkers?
por: Gunasekaran, Pradeep Moon, et al.
Publicado: (2019) -
The kinetic requirements of extreme qPCR
por: Millington, Adam L., et al.
Publicado: (2019) -
Development of event-specific qPCR detection methods for genetically modified alfalfa events J101, J163 and KK179
por: Guertler, Patrick, et al.
Publicado: (2019)